Related Experiment Video
Updated: Apr 21, 2026
Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
Published on: June 14, 2019
Gynecologic Cancer InterGroup (GCIG) consensus review for small cell carcinoma of the cervix
Toyomi Satoh1, Yuji Takei, Isabelle Treilleux
1*University of Tsukuba, Tsukuba-City, Japan and GOTIC; †Jichi Medical University, Shimono-City, Japan and GOTIC; ‡Centre Leon Berard, Lyon, France and GINECO; §Hospices Civils de Lyon, France and GINECO; ∥University College of London, London, UK and NCRI/MRC; ¶Harvard Medical School, Boston, MA and RTOG; #Universtatsklinikum Hamburg-Eppendorf, Hamburg, Germany and AGO; **University of Montreal, Montreal, Quebec, Canada and NCIC-GCT; ††Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia and ANZGOG; ‡‡Karolinska Institute, Stockholm, Sweden and NSGO; §§Insitut Gustave Roussy, Villejuif, France and GINECO; ∥∥Beatson Oncology Centre, Glasgow, UK and EORTC; and ¶¶Saitama Medical University International Medical Center, Hidaka-City, Japan and GOTIC.
Abstract:
Small cell carcinoma of the cervix (SCCC) is a rare histological entity of uterine cervical cancer. Compared with other common histological types, squamous cell carcinoma or adenocarcinoma, the outcome of SCCC is poor because of the high incidence of nodal or distant metastasis even with early stage. In this review, current consensus of epidemiology, pathology, and initial treatment for SCCC will be discussed.
